Clinical Trial Update: Rocklatan® Evaluation [Phase 4]

View source ↗

Summary

Phase 4 trial update for Rocklatan evaluated in glaucoma has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2024-04-03